blog_reportThroughout the year the BIA advocates for our members in the UK life science industry, engaging with decision makers and influencers in Westminster, Whitehall and across the science, health and business sectors, as well as with regulators in the UK and Europe. Our latest quarterly report, ‘Influencing and shaping our sector: BIA update July – October 2015’, sets out what we’ve been up to in the last few months.

You can download the report in full here. Highlights include:

blog_FT letter

  • Our work ahead of the Government’s Spending Review on 25 November to illustrate why public funding for science and innovation is so vital. We’ve undertaken a range of activities on behalf of industry and in collaboration with the wider life science community. If you want to add your voice please do contact us!
  • Our activities across blog_labour tablethis autumn’s party conference season, including our joint roundtable discussions as part of Life Sciences UK (ABHI, ABPI, BIA and BIVDA) at the Labour and Conservative party conferences. We also review the new Labour landscape following the installation of Jeremey Corbyn as new Labour leader and his shadow ministerial team.
  • An update on Patent Box developments. Following the completion of talks at an international level by the G20 and the OECD on the Base Erosion and Profit Shifting (BEPS) project, HM Treasury has issued its consultation on the implementation of the reforms into the UK. Find out more about the changes and our efforts to demystify the policy and potential business implications, starting with the publication of an overview paper – Changes to the UK Patent Box: An Overview, October 2015 – which was prepared in partnership with Confluence Tax.
  • Details on the recently announced PRIME scheme – a new scheme, developed by the European Medicines Agency (EMA) and the EU Regulatory Network, to support development of priority medicines addressing major public health needs. The BIA will be inputting to the public consultation issued on 26 October on the key elements of the scheme, which is scheduled to launch in Q1 2016.

We’re always keen to hear from our members. Which policy areas do you care about; what’s impacting your business and R&D? Do you have a story that would help us to make the case for continuity in what works and to change what doesn’t?

To learn more about BIA’s policy, public affairs and regulatory affairs work, see our previous quarterly policy updates, our consultation responses, or email Zoë with any questions.